Tg Therapeutics (TGTX) Preferred Shares (2011 - 2012)

Tg Therapeutics (TGTX) recorded quarterly Preferred Shares of $1109.0 in Q1 2012, up 168.52% quarter-over-quarter from $413.0 in Q4 2011.

Tg Therapeutics (TGTX) Preferred Shares (2011 - 2012) Analysis & Trends

Tg Therapeutics' Preferred Shares history runs 2 years deep, the most recent figure standing at $1109.0 for Q1 2012.

In Q1 2012, Preferred Shares changed N/A year-over-year to $1109.0; the TTM figure through Mar 2012 stood at $1109.0 (changed N/A YoY), while the FY2012 annual figure was $1109.0, changed N/A from the prior year.
Preferred Shares was $1109.0 for Q1 2012 at Tg Therapeutics, up from $413.0 in the prior quarter.
In the past five years, Preferred Shares ranged from a high of $1109.0 in Q1 2012 to a low of $413.0 in Q4 2011.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Shares (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	-
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	-
9	Abivax	91.96 Bn	91.96 Bn	-	-
10	Tg Therapeutics	7.71 Bn	7.06 Bn	171.41 Mn	-

Download Data

Date	Value
Mar 31, 2012	1,109.00
Dec 31, 2011	413.00